Amarant Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 8 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 176.87%
- Profit Growth 399.02%
- Ebitda 174.79%
- Net Worth 180.59%
- Total Assets 134.13%
About Amarant Lifesciences
Amarant Lifesciences Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 January 2012 and has a history of 13 years. Its registered office is in Delhi, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bharti Khanna and Sangeet Khanna serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999DL2012PTC230408
-
Company No.
230408
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Jan 2012
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Amarant Lifesciences Private Limited offer?
Amarant Lifesciences Private Limited offers a wide range of products and services, including Job Consultation Service, Recruitment Service.
Who are the key members and board of directors at Amarant Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bharti Khanna
|
Director | 23-Jan-2012 | Current |
|
Sangeet Khanna
|
Director | 26-Sep-2023 | Current |
Financial Performance of Amarant Lifesciences.
Amarant Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 176.87% increase. The company also saw a substantial improvement in profitability, with a 399.02% increase in profit. The company's net worth Soared by an impressive increase of 180.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amarant Lifesciences?
Unlock access to Amarant Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Concord Biotech LimitedBharti Khanna is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amarant Lifesciences?
Unlock and access historical data on people associated with Amarant Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amarant Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amarant Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
